Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy

被引：0
|
作者：
Ryutaro Shimizu
Masashi Honda
Shogo Teraoka
Tetsuya Yumioka
Noriya Yamaguchi
Bunya Kawamoto
Hideto Iwamoto
Shuichi Morizane
Katsuya Hikita
Atsushi Takenaka
机构：
[1] Tottori University,Division of Urology, Department of Surgery, Faculty of Medicine
来源：
International Journal of Clinical Oncology | 2022年 / 27卷
关键词：
Sarcopenia; Urothelial carcinoma; Prognostic factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：175 / 183
页数：8
相关论文
共 50 条
  • [21] Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy
    Fossa, SD
    Sternberg, C
    Scher, HI
    Theodore, CH
    Mead, B
    Dearnaley, D
    Roberts, JT
    Skovlund, E
    BRITISH JOURNAL OF CANCER, 1996, 74 (10) : 1655 - 1659
  • [22] Prognostic model to predict survival in patients with metastatic upper tract urothelial carcinoma treated with cisplatin-based chemotherapy
    Hsieh, Meng-Che
    Su, Yu-Li
    Chiang, Po-Hui
    Rau, Kun-Ming
    Chen, Yen-Yang
    Huang, Cheng-Hua
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (05) : 385 - 389
  • [23] Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab
    Tomisaki, Ikko
    Harada, Mirii
    Sakano, Shigeru
    Terado, Michikazu
    Hamasuna, Ryoichi
    Harada, Shuji
    Matsumoto, Hiroomi
    Akasaka, Soichiro
    Nagata, Yujiro
    Minato, Akinori
    Harada, Ken-ichi
    Fujimoto, Naohiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (09) : 738 - 745
  • [24] Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy
    Kerioui, M.
    Desmee, S.
    Mercier, F.
    Lin, A.
    Wu, B.
    Jin, J. Y.
    Shen, X.
    Le Tourneau, C.
    Bruno, R.
    Guedj, J.
    ESMO OPEN, 2022, 7 (01)
  • [25] Improved Survival With The Addition Of Pelvic Radiotherapy To Chemotherapy In Patients With Metastatic Urothelial Carcinoma
    Fischer-Valuck, B. W.
    Carmona, R.
    Patel, S. A.
    Christodouleas, J. P.
    Rao, Y. J.
    Arora, V.
    Kim, E.
    Picus, J.
    Roth, B.
    Sargos, P.
    Smith, Z.
    Zaghloul, M. S.
    Gay, H. A.
    Michalski, J. M.
    Baumann, B. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E913 - E914
  • [26] Re: Neoadjuvant Chemotherapy Improves Survival of Patients with Upper Tract Urothelial Carcinoma
    Laguna, M. Pilar
    JOURNAL OF UROLOGY, 2014, 192 (05): : 1366 - 1366
  • [27] Survival Benefit for Patients With Metastatic Urothelial Carcinoma Receiving Continuous Maintenance Chemotherapy
    Liaw, Chuang-Chi
    Liao, Tzu-Yao
    Tsui, Ke-Hung
    Juan, Yu-Hsiang
    IN VIVO, 2019, 33 (04): : 1249 - 1262
  • [28] IMPACT OF SARCOPENIA ON SURVIVAL OF PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Reggidori, N.
    Lani, L.
    Renzulli, M.
    Gramenzi, A.
    Iannone, G.
    Granito, A.
    Piscaglia, F.
    Golfieri, R.
    Trevisani, F.
    Biselli, M.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S151 - S151
  • [29] Survival and prognostic stratification of patients with metastatic urothelial cancer who underwent systemic chemotherapy
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 292 - 292
  • [30] Prognostic factors fdr survival in advanced and metastatic urothelial cell carcinoma (UCC) treated with chemotherapy
    van der Rijt, CCD
    Splinter, TAW
    Schmitz, PIM
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S19 - S19
12345